In vivo thermoluminescence dosimetry dose verification of transperineal 192Ir high-dose-rate brachytherapy using CT-based planning for the treatment of prostate cancer

International Journal of Radiation Oncology Biology Physics

Volumn 57, Issue 4, 2003, Pages 1183-1191

  Anagnostopoulos, G ^a   Baltas, D ^a,b   Geretschlaeger, A ^a   Martin, T ^a   Papagiannis, P ^c   Tselis, N ^a   Zamboglou, N ^a  

^a Klinikum Offenbach GmbH   (Germany)

^b NATIONAL TECHNICAL UNIVERSITY OF ATHENS   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

Brachytherapy; In vivo; Prostate; TLD

Indexed keywords

CATHETERS; DOSIMETRY; ONCOLOGY; THERMOLUMINESCENCE; TUMORS;

TREATMENT PLANNING SYSTEMS;

RADIOTHERAPY;

IRIDIUM 192;

ACCURACY; ANALYTICAL ERROR; ARTICLE; BRACHYTHERAPY; CATHETER; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; THERMOLUMINESCENCE DOSIMETRY;

EID: 0142217866     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(03)00762-4     Document Type: Article

References (39)

1. 192Iridium prostate brachytherapy Feasibility report. Int J Radiat Oncol Biol Phys. 41:1998;525-533.
2. Martinez A.A., Kestin L.L., Stromberg J.S., et al. Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer The William Beaumont phase II dose-escalating trial. Int J Radiat Oncol Biol Phys. 47:2000;343-352.
3. Stromberg J., Martinez A., Gonzalez J., et al. Ultrasound-guided high dose rate conformal brachytherapy boost in prostate cancer Treatment description and preliminary results of a phase I/II clinical trial. Int J Radiat Oncol Biol Phys. 33:1995;161-171.
4. Martinez A.A., Gustafson G., Gonzalez J., et al. Dose escalation using conformal high-dose-rate brachytherapy improves outcome in unfavorable prostate cancer. Int J Radiat Oncol Biol Phys. 53:2002;316-327.
5. Galalae R.M., Kovacs G., Schulize J., et al. Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer. Int J Radiat Oncol Biol Phys. 52:2002;81-90.
6. Yoshioka Y., Nose T., Yoshida K., et al. High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer Treatment description and preliminary results of a phase I/II clinical trial. Int J Radiat Oncol Biol Phys. 48:2000;675-681.
7. Martinez A.A., Pataki I., Edmundson G., et al. Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer A feasibility report. Int J Radiat Oncol Biol Phys. 49:2001;61-69.
8. Nath R., Anderson L.L., Meli J.A., et al. Code of practise for brachytherapy physics Report of the AAPM Radiation Therapy Committee Task Group 56. Med Phys. 24:1997;1557-1598.
9. Houdek P.V., Schwade J.G., Wu X., et al. Dose determination in high dose-rate brachytherapy. Int J Radiat Oncol Biol Phys. 24:1992;795-801.
10. Meigooni A.S., Williamson J.F., Slessinger E.D. Practical quality assurance tests for positional and temporal accuracy of HDR remote afterloaders. Endocurie Hypertherm Oncol. 9:1993;46.
11. DeWerd L.A., Jursinic P., Kitchen P., et al. Quality assurance tool for high dose rate brachytherapy. Med Phys. 22:1995;435-440.
12. Bastin K.T., Podgorsak M.B., Thomadsen B.R. The transit dose component of high dose rate brachytherapy Direct measurements and clinical implications. Int J Radiat Oncol Biol Phys. 26:1993;695-702.
13. Podgorsak M.B., Paliwal B.R., Thomadsen B.R., et al. Radiographic visualization of vaginal cylinders in gynecologic high dose-rate brachytherapy. Int J Radiat Oncol Biol Phys. 25:1993;252-257.
14. 192Ir sources. Int J Radiat Oncol Biol Phys. 14:1988;587-594.
15. Mangold C.A., Rijnders A., Georg D., et al. Quality control in interstitial brachytherapy of the breast using pulsed dose rate Treatment planning and dose delivery with an Ir-192 afterloading system. Radiother Oncol. 58:2001;43-51.
16. Duan J., Macey D.J., Pareek P.N., et al. Real-time monitoring and verification of in vivo high dose brachytherapy using a pinhole camera. Med Phys. 28:2001;167-173.
17. Alecu R., Alecu M. In-vivo dose measurements with diodes to avoid misadministrations during intracavitary high dose rate brachytherapy for carcinoma of the cervix. Med Phys. 26:1999;768-770.
18. Brezovich I.A., Duan J., Pareek P.N., et al. In vivo urethral dose measurements A method to verify high dose rate prostate treatments. Med Phys. 27:2000;2297-2301.
19. Milickovic N., Giannouli S., Baltas D., et al. Catheter autoreconstruction in CT based brachytherapy treatment planning. Med Phys. 27:2000;1047-1059.
20. Giannouli S., Baltas D., Milickovic N., et al. Autoactivation of source dwell positions for HDR brachytherapy treatment planning. Med Phys. 27:2000;2517-2520.
21. Nath R., Anderson L.L., Luxton G., et al. Dosimetry of interstitial brachytherapy sources Recommendations of the AAPM Radiation Therapy Committee Task Group 43. Med Phys. 22:1995;209-234.
22. Williamson JF, Meigooni AS. Quantitative dosimetry methods in brachytherapy. In: Brachytherapy Physics AAPM Summer School. Medical Physics Publishing 1994; p. 87-133.
23. Cameron JR, Suntharalingam N, Kenney GN. Thermoluminescent dosimetry. Madison, WI: University of Wisconsin; 1968.
24. Weller M.K., Slessinger E.D., Wong J.W., et al. A practical method for precise thermoluminescent dosimetry. Treat Plan. 8:1983;22-26.
25. Meigooni A.S., Meli A.J., Nath R. Influence of the variation of energy spectra with depth in the dosimetry of Ir-192 using LiF TLD. Phys Med Biol. 33:1988;1159-1170.
26. 192Ir high dose-rate brachytherapy source. Med Phys. 25:1998;1975-1984.
27. 192Ir HDR sources. Med Phys. 27:2000;1025-1029.
28. 192Ir high-dose rate brachytherapy sources. Int J Radiat Oncol Biol Phys. 43:1999;653-661.
29. 192Ir Afterloadingstrahler mit einem PMMA- Zylinderphantom. Z f Med Phys 1991;1:38-41.
30. 192Ir sources. Med Phys. 22:1995;809-820.
31. Karaiskos P., Sakelliou L., Sandilos P., et al. Limitations of the point and line source approximations for the determination of geometry factors around brachytherapy sources. Med Phys. 27:2000;124-128.
32. 192Ir brachytherapy sources. Phys Med Biol. 43:1998;1783-1801.
33. 125I interstitial brachytherapy seed. Med Phys. 29:2002;709-716.
34. Wong T.P.V., Fernando W., Johnston P.N., et al. Transit dose of an Ir-192 dose rate brachytherapy stepping source. Phys Med Biol. 46:2001;323-331.
35. Sahoo N. Measurement of transit time of a remote after-loading high dose rate brachytherapy source. Med Phys. 28:2001;1786-1789.
36. Williamson J.F., Ezzell G.A., Olch A., Thomadsen B.R. Quality assurance for high dose rate brachytherapy. Nag S. High dose rate brachytherapy: A text book. 1994;147-212 Futura, Armonk, NY.
37. Damore S.J., Syed A.M.N., Puthawala A.A., et al. Needle displacement during HDR brachytherapy in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 46:2000;1205-1211.
38. 192Ir brachytherapy stepping source. Med Phys. 27:2000;129-131.
39. 192Ir HDR prostate monotherapy using polymer gels and MRI (accepted for publication in Med Phys).